Epalrestat
Epalrestat núm. CAS: 82159-09-9
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat s’utilitza per prevenir, millorar i tractar la neuropatia perifèrica (entumiment, dolor), parestèsia vibracional i anomalia cardíaca associada a la diabetis. ESPECIFICACIÓ
Epalrestat is a non-competitive inhibitor of aldose reductase, which reversibly inhibits the conversion of glucose into sorbitol aldose reductase in polyol metabolism associated with the pathogenesis of diabetic complications, and can significantly improve The patient's symptoms and neurological dysfunction improve their motor nerve conduction velocity and autonomic function.
Epalrestat s’utilitza per prevenir, millorar i tractar la neuropatia perifèrica (entumiment, dolor), parestèsia vibracional i anomalia cardíaca associada a la diabetis. ESPECIFICACIÓ
| P nom roduct | Epalrestat |
| CAS | 82159-09-9 |
| MF: | C15H13NO3S2 |
| MW: | 319.4 |
Escriviu aquí el vostre missatge i envieu-nos-el
